Research Article
IL-20R Activation via rIL-19 Enhances Hematoma Resolution through the IL-20R1/ERK/Nrf2 Pathway in an Experimental GMH Rat Pup Model
Figure 1
Experimental design and animal groups. Extra 2 pups were used for IF (IL-20R1, IL-20R2, and CD11b) at 72 hours after GMH. Assumed the optimal dose group.